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Abstract
Background: Many risk factors for fractures have been documented, including low bone-mineral
density (BMD) and a history of fractures. However, little is known about the short-term absolute
risk (AR) of fractures and the timing of clinical fractures. Therefore, we assessed the risk and timing
of incident clinical fractures, expressed as 5-year AR, in postmenopausal women.
Methods: In total, 10 general practice centres participated in this population-based prospective
study. Five years after a baseline assessment, which included clinical risk factor evaluation and BMD
measurement, 759 postmenopausal women aged between 50 and 80 years, were re-examined,
including undergoing an evaluation of clinical fractures after menopause. Risk factors for incident
fractures at baseline that were significant in univariate analyses were included in a multivariate Cox
survival regression analysis. The significant determinants were used to construct algorithms.
Results:  In the total group, 12.5% (95% confidence interval (CI) 10.1–14.9) of the women
experienced a new clinical fracture. A previous clinical fracture after menopause and a low BMD
(T-score <-1.0) were retained as significant predictors with significant interaction. Women with a
recent previous fracture (during the past 5 years) had an AR of 50.1% (95% CI 42.0–58.1) versus
21.2% (95% CI 20.7–21.6) if the previous fracture had occurred earlier. In women without a
fracture history, the AR was 13.8% (95% CI 10.9–16.6) if BMD was low and 7.0% (95% CI 5.5–8.5)
if BMD was normal.
Conclusion: In postmenopausal women, clinical fractures cluster in time. One in two women with
a recent clinical fracture had a new clinical fracture within 5 years, regardless of BMD. The 5-year
AR for a first clinical fracture was much lower and depended on BMD.
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Background
According to the World Health Organization (WHO),
osteoporosis is the second leading health problem in the
developed world in terms of numbers [1,2], owing to the
ageing of the western female population [1-9]. The inci-
dence of fractures is related to the age of the population,
and to skeletal and extra-skeletal factors [1-9]. The world-
wide lifetime risk of osteoporotic fractures in women is
40%, and because of the ageing of the population, the
overall prevalence of osteoporotic fractures is expected to
rise considerably [10]. The mortality rate for hip fractures
varies between 15 and 30% [10-12]. In 1990, there were
1.7 million hip fractures worldwide, and this could
increase to 6.3 million by 2050 [10]. The resulting hospi-
tal costs alone amount to over US$3976 million in the
European Union, US$500 million in Australia, US$5700
million in the USA, and US$9359 million in Japan [10].
In view of this high morbidity, mortality and economic
burden, it is important to identify those groups of patients
who are at high risk and for whom interventions to pre-
vent osteoporotic fractures would be most effective [3,4,6-
9].
In 1992–1994, a cross-sectional population-based study
assessed BMD and other determinants that might influ-
ence osteoporosis among 4203 postmenopausal women
aged 50 to 80 [7-9]. A random sample of women from the
above study was re-examined 5–6 years later, allowing us
to study the prognostic value of relevant determinants of
experiencing a fracture.
Several researchers have addressed the same subject [13-
22], and the WHO is currently developing a fracture risk
assessment tool with which family physicians can predict
5-year and 10-year fracture risk [23]. However, data are
scarce about the absolute risk (AR) of fractures and the
timing of a previous clinical fracture [14-16]. Available
studies suggest that fracture risk is highest immediately
after a fracture, with the risk of an osteoporotic fracture
being 12.0%[14] and that of any fracture being 12.2%
during the first 2 years[16]. The risk of morphological ver-
tebral fractures is 19.2% at 1 year after a previous morpho-
logical vertebral fracture[15]. The goal of our study was to
assess the 5-year AR of incident clinical fractures among
postmenopausal women.
Methods
Ethics
The ethics review committee of the Maastricht University
and the Maastricht University Hospital approved the
study (reference number MEC 94-196.1).
Participants
In total, 20 general practitioners (GPs) from 10 general
practice centres participated. The participating general
practices were invited based on their familiarity with the
rules of 'good clinical practice' and based on their partici-
pation in earlier studies. The region can best be described
as consisting of two cities surrounded by suburban vil-
lages [7].
A random sample of 1686 postmenopausal women, aged
between 50 and 80 years, was drawn from the above study
population [7-9]. Participating women signed an
informed consent form.
Measurements
The assessments in 1992–1994 started with weight (in kil-
ograms), height (in centimetres), and BMD (measured by
a computer-guided DXA instrument; Hologic QDR-1000,
Hologic Europe, Brussels, Belgium). Four experienced and
specially trained research nurses performed all the meas-
urements. After the measurements, the participants com-
pleted a questionnaire, which concentrated on variables
possibly related to osteoporosis or low BMD [7-9]. In
addition, all women were questioned about their medical
history (including fracture history), family history and
diet [7].
In the 1998–2000 assessments, one specially trained
research nurse, or the principal investigator, completed a
questionnaire in the presence of the participant, which
recorded the history of fractures. The research assistant
confirmed all fractures reported by the patients by search-
ing the medical files in the participating GP centres. In the
Netherlands, clinical fractures are treated in hospital and
then reported to the patient's GP, who always includes
this information in the patient's medical file. In our study,
every fracture reported by a patient could thus be con-
firmed by her medical file.
Statistical analysis
SPSS software (version 11.0; SPSS Inc., Chicago, IL, USA)
was used for the statistical analysis. The dependent varia-
ble was the first fracture suffered by a woman after base-
line, taking only the first fracture after menopause into
account. A power calculation for our main variable (tim-
ing of a previous fracture) was performed. This calculation
compared two proportions [24].
The hazard of first fracture and the death hazard were used
to compute the 5-year probability of fractures. Univariate
Cox regression analysis was used to analyse possible pre-
dictors of suffering a fracture. Before being entered into
the regression analysis, the non-discrete variables were
dichotomised at the mean. The cutoff points for coffee
intake per day and alcohol intake per week were set at five
or more consumptions. The variables 'smoking' and
'sports', both past and present, were dichotomised as yes/
no. The resulting significant variables were entered into aBMC Medicine 2006, 4:24 http://www.biomedcentral.com/1741-7015/4/24
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multivariate Cox regression to calculate the 5-year proba-
bility of fracture.
Further analysis investigated the influence of timing of a
previous clinical fracture. A discrete variable was used, cat-
egorised as participants with a recent previous fracture (in
the past 5 years; n = 68) and participants with an older
previous fracture (longer than 5 years previously, but still
after menopause; n = 62). The 5-year cutoff point was the
optimum compromise between finding a sufficient
number of fractures to allow statistical evaluation and
minimising the loss to recall [7]. Thereafter, a multivariate
subgroup analysis was performed, including the timing of
previous fractures. These significant determinants were
used to construct algorithms, which included relative risk
(RR), AR and 95% confidence intervals (CI).
At baseline (1992–1994), BMD values for lumbar spine
were divided into two categories: BMD T-score <-1.0
(including osteoporosis plus osteopenia) and T-score ≥ -
1.0, according to WHO criteria [1].
Results
Of the 1686 women, 1207 were traceable and alive, and
759 agreed to take part in the follow-up measurement.
This corresponded to a response rate of 62.9% of the
traceable and surviving women (Figure 1). Non-partici-
pating women were compared with participating women
in terms of the baseline variables. Age was the only varia-
ble that differed between the responders and non-
responders; non-participants were on average 3.5 years
older than participants.
The power calculation compares a recent previous fracture
(n = 68) versus an older previous fracture (n = 62). The
two proportions were 0.50 (34/68) and 0.19 (12/62),
which resulted in a two-sided power of 0.95. This result
showed that the study was sufficiently powered.
The characteristics of the study population at baseline
(1992–1994) are shown in Tables 1 (non-discrete varia-
bles) and 2 (discrete variables). In total, 95 women
(12.5%; 95% CI 10.1–14.9) had a clinical fracture during
the 5-year follow-up (Table 3).
The univariate Cox regression showed that low BMD (T <
-1.0), increasing age, a history of clinical fracture after
menopause, coffee intake, and current or past smoking
were significant predictors of a new clinical fracture (Table
4).
As shown in Table 1, there seemed to be some very low
values for calcium intake. In an extended univariate Cox
regression analysis to investigate the influence of this fac-
tor, the lowest quintile and quartile of calcium intake
were excluded. This exclusion did not change the results
[hazard ratio (HR) = 1.4, 95% CI 0.9–2.2, and HR = 1.3,
95% CI 0.8–2.0, respectively].
These significant determinants were entered into a multi-
variate Cox regression. The results of this analysis showed
that a previous fracture (HR = 5.0, 95% CI 3.4–7.5) was a
significant risk factor, and an interaction was found
between a previous fracture and BMD. Low BMD contrib-
uted significantly only in the presence of interaction, and
was therefore an effect modifier. Low BMD was not a sig-
nificant predictor for patients with a previous fracture (n
= 130; HR = 1.5, 95% CI 0.8–2.9), but was for those with-
out (n = 629; HR = 2.9, 95% CI 1.5–5.8).
Table 3 shows the details of 31 hand, foot and other frac-
tures stated. Of these 31 fractures, 12 were caused by a
traumatic accident (for example, fall from stairs or bicycle,
or fractures incurred during sports). We therefore
excluded these 12 fractures from an extended analysis.
Multivariate Cox regression again showed that a previous
fracture (HR = 5.0, 95% CI 3.2–7.8) was the most signifi-
cant risk factor. Furthermore, low BMD contributed sig-
nificantly only in the presence of an interaction, and was
a significant predictor only for those without a previous
fracture (n = 629; HR = 2.5, 95% CI: 1.2–5.0). Thus, we
found that excluding the fractures caused by a trauma did
not change the results and they were therefore not
excluded from further analysis. 
The multivariate subgroup analysis, including the timing
of a previous fracture, showed that a recent previous frac-
ture contributed significantly more to the risk of a new
clinical fracture than did an older previous fracture (HR =
3.2, 95% CI: 1.7–6.3). Thus, whether a previous fracture
was recent was an important risk factor for suffering a new
clinical fracture. This result is illustrated in the cumulative
survival plot of the postmenopausal women with a previ-
ous fracture (Figure 2), and shows clearly that a recent pre-
Flow chart of patient inclusion Figure 1
Flow chart of patient inclusion.
1686
272 (no cooperation by GP)
1414
207 (untraceable or deceased)
1207
448 (no cooperation by patients)
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vious fracture was a much more important risk factor than
an older previous fracture (R2 = 0.98 for an exponential
trend line and 0.76 for a linear trend line).
The AR for incident clinical fracture was 50.1% (95% CI
42.0–58.1) in women with a recent previous fracture, and
21.2% (95% CI 20.7–21.6) in women with an older pre-
vious fracture (Figure 3). In women without a fracture his-
tory after menopause, BMD was a significant predictor.
The participants without a fracture history and with nor-
mal BMD (T ≥ -1.0) had an AR of 7.0% (95% CI 5.5–8.5).
This risk was 44.0% lower than that in the total study pop-
ulation (12.5%), and this subgroup represented 35.0% of
the total study population. Women without a previous
fracture and with low BMD had an AR of 13.8% (95% CI
10.9–16.6), which was 10.4% higher than that of the total
study population (Figure 3).
Discussion
The results show that clinical fractures in postmenopausal
women cluster in time. One in two women with a recent
previous clinical fracture had a new clinical fracture
within 5 years, regardless of BMD. The 5-year AR for a first
clinical fracture was much lower and depended on BMD.
The HR of a previous fracture (5.0) is higher than the 2.0
reported in a large meta-analysis[5]; however, our analysis
showed that having an older previous fracture (n = 62) led
to an HR of 2.5 (95% CI 1.3–4.8), which is closer to the
reported AR. The results show that a recent previous frac-
ture is a more important predictor of a new clinical frac-
ture than is an older previous fracture. Owing to effect
modification, the algorithm differs between the sub-
groups with and without a previous fracture, leading to a
stronger prediction model per subgroup. This allowed a
low-risk group (35.0%) to be identified, consisting of
women who can be spared a great deal of unnecessary
worry. Nevertheless, 17.2% of the population were at very
high risk.
The incidence of vertebral fractures may have been under-
estimated in our study because only clinical fractures were
used. Morphometric fractures that do not come to clinical
attention have significance and are not without symp-
toms[25,26]. Kanis et al[27] showed that the 10-year ver-
tebral probability of morphometric fractures was higher
than for clinical fractures alone. Furthermore, morpho-
Table 2: Description of the study population at baseline (1992–
1994) discrete variables (n = 759)
Variable Risk factor present Percentage
Osteoporosis (T < -2.5) 155 20.4
Osteopenia (-2.5 ≥ T < -1.0)) 306 40.3
Normal BMD (T ≥ -1.0) 298 39.3
Fracture history after menopause 130 17.1
Use of birth control pill >5 years 132 17.4
Use of hormones >5 years 48 6.3
Ovariectomy 116 15.3
Hysterectomy 287 37.8
Menopause before the age of 45 255 33.6
Perimenopausal complaints 226 29.8
Family history of osteoporosis 96 12.6
Coffee intake ≥ 5 per day 379 49.9
Alcohol intake ≥ 5 per week 109 14.4
Smoking (past) 157 20.7
Smoking (present) 200 26.4
Sports (present) 469 61.8
Sports (past) 455 59.9
Occupational exercise in the past
Mild 122 16.1
Moderate 610 80.4
High 24 3.2
BMD = bone mineral density
Table 1: Description of the study population at baseline (1992–1994) non-discrete variables (n = 759)
Variable Mean SD Range
BMD (g/cm2) 0.94 0.17 0.46–1.59
Age (years) 61.0 6.8 50.1–79.4
Weight (kg) 70.9 11.6 45.0–115.5
Height (cm) 162 6.2 142–183
BMI (kg/m2) 27.1 4.2 18–45
Fertility years* 33.0 6.4 5–46
Pregnancies 2.9 2.1 0.0–14
Coffee consumptions/day 5.1 3.3 0.0–30
Alcohol consumptions/week 1.8 5.3 0.0–77
Cigarettes/day smoked in the past 3.4 8.5 0.0–50
Years of smoking in the past 4.8 11.3 0.0–54
Cigarettes/day smoked in the present 3.9 7.7 0.0–50
Years of smoking in the present 9.2 16.3 0.0–57
Calcium intake (mg) 903 407 133–2812
BMD, bone mineral density; BMI, body mass index
*Fertility years = age of last menstruation minus age of first menstruationBMC Medicine 2006, 4:24 http://www.biomedcentral.com/1741-7015/4/24
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metric fractures increase the risk of a new clinical fracture
significantly and are, therefore, of prognostic signifi-
cance[15]. BMD, especially measured at the spine, is a
strong predictor of a first vertebral fracture[28]. All
women in our study with a clinical vertebral fracture (n =
7) had a low BMD. Thus, our AR is generally an underes-
timate compared with the AR of fractures found when all
morphometric fractures were taken into account.
The factors that were independent and significant predic-
tors of fracture risk in our study have been investigated
previously, leading to partly comparable results. How-
ever, limited data are available about absolute fracture risk
and the timing of a previous clinical fracture [14-16] when
controlling for most other risk factors. Our study differs
from previous in some methodological aspects. Firstly,
some studies used prospective data, but presented a risk
prediction tool for 1 year[14-16,22,29], which could be
too short a time span. Secondly, many studies developed
a prediction model specially for hip or vertebral fractures
[13,15,17-20], while we included all fractures. Finally,
previous results may have differed from ours in terms of
geographical factors. For example, the participants of the
Dubbo Osteoporosis Study [20] lived in a region with
considerably more sun shine than in northern Europe
[30,31], which might result in different vitamin D levels.
Age has been documented as a risk factor for fractures in
several studies. In our study, age was a significant risk fac-
tor for a new clinical fracture only in the univariate analy-
sis. One reason could be that we studied a relatively young
population compared with other prospective studies, and
the timing of a previous fracture is the main risk for new
fractures for this population. All women were aged 50–80
years, with only 12.0% of the population aged 70 years
and over, whereas women included in other studies were
aged 65 years and over [19-21]. It is possible that our ARs
are an underestimate, due to the 3.5-year age difference
between the responders and non-responders. However,
our results hardly differ from other studies, such as that of
Johnell et al[32]. Based on person-years, our absolute frac-
ture risk was 2.7% (95/3542), which is close to the AR
reported by Johnell et al (AR: 2.2%; 3694/168 366)[32].
Our study was subject to some limitations. BMD measure-
ment was performed on the lumbar spine, a measurement
that can be influenced by osteoarthritis among the elderly.
Measurements at the hip could have given additional
information, but this had not been performed at baseline
(1992–1994). Furthermore, 45 participants (5.9%)
received advice about calcium intake and exercise after
baseline measurements. Some participants may have
heeded this advice, and may therefore have improved
their lifestyle. However, the advice differed little from the
recommendations regularly made to the general public,
Table 4: Univariate Cox regression, hazard ratio and 95% 
confidence interval (n = 759)
Variable Hazard ratio 95% CI
BMD ≤ 0.95 g/cm2 1.8 1.2–2.8
Osteoporosis* 1.5 0.9–2.3
Osteopenia* 1.3 0.9–2.0
Low BMD* 1.9 1.2–3.1
Age > 60 years 1.7 1.1–2.6
Weight ≤ 70 kg 1.2 0.8–1.8
Height >160 cm 1.0 0.6–1.5
BMI ≤ 27 kg/m2 1.1 0.8–1.7
Fertility years ≤ 35 years 1.0 0.7–1.6
Pregnancies > 3 1.4 0.9–2.1
Calcium intake ≤ 900 mg 1.3 0.9–2.0
Fracture history after menopause 5.2 3.4–7.7
Use of birth control pill > 5 years 1.2 0.7–1.9
Use of hormones >5 years 3.3 0.8–13.6
Ovariectomy 1.1 0.7–1.9
Hysterectomy 1.1 0.7–1.7
Menopause below the age of 45 1.2 0.8–1.8
Perimenopausal complaints 1.4 0.9–2.3
Family history of osteoporosis 1.2 0.7–2.1
Coffee intake ≥ 5 per day 1.3 0.9–1.9
Alcohol intake ≥ 5 per week 1.0 0.6–1.8
Smoking (past)† 1.6 1.0–2.4
Smoking (present)† 1.7 1.0–2.8
Sports (past)† 1.0 0.6–1.4
Sports (present)† 1.0 0.6–1.5
Occupational exercise in the past
Mild 0.3 0.0–2.1
Moderate 0.8 0.5–1.4
High Reference Reference
BMD, bone mineral density; BMI, body mass index.
*Osteoporosis = T <-2.5; osteopenia = T >-2.5 and T < -1.0; low 
BMD = T <-1.0.
†Smoking past and present, and sports past and present were 
dichotomised as yes/no.
Table 3: Location and number of fractures during the follow-up 
period
Location Number
Vertebra 7
Rib 2
Upper extremities
Humerus 14
Wrist 30
Hand 5
Other 8
Lower extremities
Hip 5
Femur 6
Foot 8
Other 10
Total 95BMC Medicine 2006, 4:24 http://www.biomedcentral.com/1741-7015/4/24
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on which women may also act. One other factor that may
have affected the results is the previous use of medication.
However, only the 45 women mentioned above were
being treated for osteoporosis (including treatment with a
placebo), and excluding these participants from the anal-
ysis did not change the results. Finally, our sample size
was relatively small in comparison with that in other stud-
ies. Johnell et al[32] studied 38 973 men and women
(75% women) from 12 prospective cohorts. The total
number of osteoporotic and non-osteoporotic fractures in
these cohorts was 3694 (AR = 9.5%)[32]. This indicates
that even though our sample was relatively small, our
absolute fracture risk was still higher than the AR of
Johnell's 12 prospective cohorts[32]. Based on person-
years instead of numbers of participants, as mentioned
previously, our absolute fracture risk was 2.7% (95/3542),
which is close to the AR reported by Johnell et al (AR =
2.2%; 3694/168 366)[32].
Conclusion
The main conclusion of our study is that a recent previous
fracture is a relevant factor in detecting postmenopausal
women at high risk. One in two women with a recent pre-
vious fracture had a new clinical fracture within 5 years,
regardless of BMD. This might be interesting information
for a variety of professionals: GPs and hospital specialists
can use it to quickly and accurately assess which postmen-
opausal women are at high or low risk, and thus, for
which women fracture prevention should be initiated
Algorithm of risk factors for a new clinical fracture Figure 3
Algorithm of risk factors for a new clinical fracture. Algorithm of risk factors for a new clinical fracture, their absolute 
risks (AR) plus 95% confidence intervals (CI), and relative risks (RR) for the subgroup with (n = 130) and without (n = 629) a 
fracture history. * Significant risk factors for a new clinical fracture based on multivariate Cox survival analysis; **reference.
A.       Previous fracture (n = 130)
Recent fracture Number of Fractures /  Percentage of the AR for RR for
(last 5-years)* participants person-years total population fractures fractures
(n=759) (CI95%)
yes 68 34/236 9.0 50.1 6.4
(42.0 to 58.1)
no 62 12/283 8.2 21.2 2.7
(20.7-21.6)
B.    No previous fracture  (n = 629)
BMD Number of Fractures /  Percentage of the AR for RR for
< -1.0* participants person-years total population fractures fractures
(n=759) (CI95%)
yes/no
yes 363 39/1724 47.8 13.8 2.0
(10.9-16.6)
no 266 10/1299 35.0 7.0 1.0**
(5.5-8.5)
Cumulative survival plot for postmenopausal women with a  previous fracture (n = 130) Figure 2
Cumulative survival plot for postmenopausal women 
with a previous fracture (n = 130). The R2 is 0.98 for an 
exponential trend line and 0.76 for a linear trend line.BMC Medicine 2006, 4:24 http://www.biomedcentral.com/1741-7015/4/24
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immediately. Future research should try to verify our
results using a longer follow-up period.
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